Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection
Authors:
- Qingsong ZouQZQingsong Zou
- Bangmin HanBHBangmin Han
- Yifeng JingYJYifeng Jing
- Di CuiDCDi Cui
- Xiao AnXAXiao An
- Yuan GaoYGYuan Gao
- Jiawei HuJHJiawei Hu
- Shujie XiaSXShujie Xia
- 12 February 2015
- journal article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 94 (4) , 406-411
Abstract
Purpose: To assess the efficacy of intra-arterial chemotherapy as a bladder-preservation treatment in patients with muscle-invasive bladder cancer (MIBC) following transurethral resection of bladder tumors (TURBT). Materials and Methods: From 2005 June to 2012 November, 46 patients diagnosed with MIBC (clinical stage T2-T3N0M0) underwent three courses of cisplatin-based intra-arterial chemotherapy as a remedial approach for bladder preservation after TURBT. All patients also received intravesical instillation of chemotherapy as a maintenance strategy. Results: All 46 patients completed the treatment with minor complications. The median follow-up time was 34.5 months (range, 8-87 months). Thirty-two patients (69.6%) demonstrated complete response. The three-year and five-year overall survival was 70.65 and 61.23%, and the disease-specific survival over the same periods was 78.03 and 67.62%, respectively. During the entire follow-up period, more than 80% preserved their bladder. Conclusions: Intra-arterial chemotherapy can be performed as a remedial treatment for MIBC patient following TURBT. Combined with TURBT, it offers an option for bladder preservation therapy on patients who are unable or unwilling to undergo radical cystectomy.Keywords
This publication has 16 references indexed in Scilit:
- Time between First and Second Transurethral Resection of Bladder Tumors in Patients with High-Grade T1 Tumors: Is It a Risk Factor for Residual Tumor Detection?Urologia Internationalis, 2013
- Bladder preservation in the treatment of muscle‐invasive bladder cancer ( MIBC ): a review of the literature and a practical approach to therapyBJU International, 2013
- Bladder conservation for muscle-invasive bladder cancerExpert Review of Anticancer Therapy, 2012
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH ExperienceEuropean Urology, 2012
- Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder CancerJournal of Urology, 2010
- Bladder Preservation Therapy Conducted by Intra-arterial Chemotherapy and Radiotherapy for Muscle Invasive Bladder CancerJapanese Journal of Clinical Oncology, 2009
- Quality control in transurethral resection of bladder tumoursBJU International, 2008
- Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving TherapyJapanese Journal of Clinical Oncology, 2007
- Organ Preservation for Muscle-Invasive Bladder Cancer by Transurethral ResectionUrology, 2007
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003